Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study

[1]  R. Premaratna,et al.  Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern –A hospital based cross sectional study , 2017, BMC Infectious Diseases.

[2]  W. Hayajneh,et al.  Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011-2013. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[3]  S. Kuo,et al.  Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[4]  P. Shao,et al.  Drug susceptibility and treatment response of common urinary tract infection pathogens in children. , 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[5]  C. Chiu,et al.  Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children. , 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[6]  D. Glikman,et al.  Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study. , 2013, The Journal of pediatrics.

[7]  X. Nassif,et al.  Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization? , 2013, The Journal of hospital infection.

[8]  M. Domínguez-Gil González,et al.  Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended‐spectrum beta‐lactamase (ESBL)‐producing enterobacteria , 2012, International journal of clinical practice.

[9]  E. Schaeffer.  Re: Extended-spectrum β-lactamase-producing gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. , 2012, The Journal of urology.

[10]  A. Elhan,et al.  Urinary tract infections owing to ESBL‐producing bacteria: microorganisms change – clinical pattern does not , 2011, Acta paediatrica.

[11]  E. Roilides,et al.  Outcome of Urinary Tract Infections Caused by Extended Spectrum &bgr;-Lactamase-producing Enterobacteriaceae in Children , 2011, The Pediatric infectious disease journal.

[12]  R. Zbinden,et al.  Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy , 2011, Infection.

[13]  N. Dalgıç,et al.  Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children , 2011, Scandinavian journal of infectious diseases.

[14]  L. Nimri.  Community-Acquired Urinary Tract Infections in a Rural Area in Jordan: Predominant Uropathogens, And their Antimicrobial Resistance , 2010 .

[15]  Ş. Çolakoğlu,et al.  Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  J. Campos,et al.  Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. , 2010, Current opinion in infectious diseases.

[17]  A. Bakkaloğlu,et al.  Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children , 2010, Pediatric Nephrology.

[18]  Y. Carmeli,et al.  A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  C. Özakın,et al.  Risk Factors in Community-Acquired/Onset Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae , 2008, Journal of chemotherapy.

[20]  G. Simmons,et al.  Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand. , 2008, The Journal of hospital infection.

[21]  K. Laupland,et al.  Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern , 2008 .

[22]  Y. Bustanji,et al.  Community consumption of antibacterial drugs within the Jordanian population: sources, patterns and appropriateness. , 2005, International journal of antimicrobial agents.

[23]  K. Angamuthu,et al.  Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. , 2005, Saudi medical journal.

[24]  G. Jacoby,et al.  Extended-spectrum beta-lactamases , 1989, Antimicrobial Agents and Chemotherapy.